Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 8.04% is 29% above its 5-year average of 6.24%, near the high end of its 5-year range (-0.71%–9.94%).
0.48% above its 12-month average of 8.00%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 9.94%.
OPERATING MARGIN
8.04%
OPERATING MARGIN AVG TTM
8.00%
OPERATING MARGIN AVG 3Y
7.22%
OPERATING MARGIN AVG 5Y
6.24%
OPERATING MARGIN AVG 10Y
5.69%
OPERATING MARGIN AVG 15Y
7.11%
OPERATING MARGIN AVG 20Y
7.12%
CURRENT VS TTM AVG
+0.48%
CURRENT VS 3Y AVG
+11.32%
CURRENT VS 5Y AVG
+28.78%
CURRENT VS 10Y AVG
+41.27%
CURRENT VS 15Y AVG
+13.15%
CURRENT VS 20Y AVG
+12.98%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
HealthStream, Inc.
Market Cap
$914.73M
Operating Margin
8.04%
TTM Avg
8.00%
3Y Avg
7.22%
5Y Avg
6.24%
Market Cap
$921.06M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$923.53M
Operating Margin
-68.62%
TTM Avg
-63.13%
3Y Avg
-82.91%
5Y Avg
-82.91%
Market Cap
$929.83M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$934.79M
Operating Margin
-449.94%
TTM Avg
-404.25%
3Y Avg
-202.12%
5Y Avg
-134.75%
Market Cap
$887.99M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$887.50M
Operating Margin
10.63%
TTM Avg
4.11%
3Y Avg
-10.10%
5Y Avg
-5.16%
Market Cap
$884.97M
Operating Margin
-192.08%
TTM Avg
-714.41%
3Y Avg
-506.77%
5Y Avg
-588.71%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HealthStream, Inc. (HSTM) | $914.73M | 8.04% | 8.00% | 7.22% | 6.24% |
| MoonLake Immunotherapeutics (MLTX)vs › | $921.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| CeriBell, Inc. (CBLL)vs › | $923.53M | -68.62% | -63.13% | -82.91% | -82.91% |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $929.83M | 0.00% | 0.00% | 0.00% | 0.00% |
| Kura Oncology, Inc. (KURA)vs › | $934.79M | -449.94% | -404.25% | -202.12% | -134.75% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bioventus Inc. (BVS)vs › | $887.50M | 10.63% | 4.11% | -10.10% | -5.16% |
| Arbutus Biopharma Corp (ABUS)vs › | $884.97M | -192.08% | -714.41% | -506.77% | -588.71% |
| Savara Inc. (SVRA)vs › | $952.91M | 0.00% | 0.00% | 0.00% | -3197.15% |
| Aktis Oncology, Inc. (AKTS)vs › | $953.81M | -1149.52% | -2324.93% | -1162.47% | -1162.47% |
Gross Margin
65.1%
Operating Margin
8.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 9.94% |
| 2026-03-31 | 9.25% |
| 2025-12-31 | 3.01% |
| 2025-09-30 | 9.89% |
| 2025-06-30 | 7.91% |
| 2025-03-31 | 5.96% |
| 2024-12-31 | 6.32% |
| 2024-09-30 | 8.89% |
| 2024-06-30 | 6.16% |
| 2024-03-31 | 7.82% |
| 2023-12-31 | 6.03% |
| 2023-09-30 | 6.91% |
| 2023-06-30 | 5.79% |
| 2023-03-31 | 4.19% |
| 2022-12-31 | 4.49% |
| 2022-09-30 | 3.54% |
| 2022-06-30 | 4.50% |
| 2022-03-31 | 6.17% |
| 2021-12-31 | -0.71% |
| 2021-09-30 | 2.79% |
| 2021-06-30 | 5.29% |
| 2021-03-31 | 5.20% |
| 2020-12-31 | 1.84% |
| 2020-09-30 | 5.15% |
| 2020-06-30 | 7.11% |
| 2020-03-31 | 11.77% |
| 2019-12-31 | 5.32% |
| 2019-09-30 | 6.00% |
| 2019-06-30 | 3.56% |
| 2019-03-31 | 8.24% |
| 2018-12-31 | 4.74% |
| 2018-09-30 | 7.78% |
| 2018-06-30 | 7.48% |
| 2018-03-31 | 6.80% |
| 2017-12-31 | 1.80% |
| 2017-09-30 | 6.27% |
| 2017-06-30 | 4.64% |
| 2017-03-31 | 3.06% |
| 2016-12-31 | -0.89% |
| 2016-09-30 | 2.20% |
| 2016-06-30 | 4.23% |
| 2016-03-31 | 4.60% |
| 2015-12-31 | 3.36% |
| 2015-09-30 | 8.03% |
| 2015-06-30 | 4.92% |
| 2015-03-31 | 10.16% |
| 2014-12-31 | 9.32% |
| 2014-09-30 | 10.65% |
| 2014-06-30 | 9.68% |
| 2014-03-31 | 8.60% |
| 2013-12-31 | 9.47% |
| 2013-09-30 | 11.52% |
| 2013-06-30 | 12.86% |
| 2013-03-31 | 10.70% |
| 2012-12-31 | 12.02% |
| 2012-09-30 | 14.14% |
| 2012-06-30 | 15.64% |
| 2012-03-31 | 9.89% |
| 2011-12-31 | 13.62% |
| 2011-09-30 | 13.07% |
| 2011-06-30 | 14.75% |
| 2011-03-31 | 13.82% |
| 2010-12-31 | 9.13% |
| 2010-09-30 | 10.17% |
| 2010-06-30 | 14.09% |
| 2010-03-31 | 9.52% |
| 2009-12-31 | 8.25% |
| 2009-09-30 | 7.65% |
| 2009-06-30 | 12.77% |
| 2009-03-31 | 6.87% |
| 2008-12-31 | 8.31% |
| 2008-09-30 | 4.32% |
| 2008-06-30 | 5.57% |
| 2008-03-31 | 0.38% |
| 2007-12-31 | 7.24% |
| 2007-09-30 | 6.18% |
| 2007-06-30 | 3.39% |
| 2007-03-31 | -1.12% |
| 2006-12-31 | 10.96% |
| 2006-09-30 | 3.94% |
| 2006-06-30 | 1.56% |
| 2006-03-31 | 7.29% |
| 2005-12-31 | 13.85% |
| 2005-09-30 | 7.05% |
| 2005-06-30 | -0.66% |
| 2005-03-31 | 0.81% |
| 2004-12-31 | -0.11% |
| 2004-09-30 | -4.81% |
| 2004-06-30 | -12.23% |
| 2004-03-31 | -9.55% |
| 2003-12-31 | -10.30% |
| 2003-09-30 | -16.32% |
| 2003-06-30 | -23.87% |
| 2003-03-31 | -33.56% |
| 2002-12-31 | -66.96% |
| 2002-09-30 | -62.87% |